Department of Medicine 5 – Haematology and Oncology

BZKF Translationsgruppe - Determination of residual disease in AML using AI-supported analysis of flow cytometry data (AML-MRD) Jan. 1, 2025 - Dec. 31, 2026 M5-IZFK-D043: Mechanisms controlling functionality and persistence of CD19.CAR T-cells March 16, 2023 - March 15, 2026 P157: Characterization of neoantigen-directed T-cell receptor-based cell therapies in a 3D breast cancer model Nov. 1, 2024 - Oct. 31, 2025 Metabolische Dysregulationen bei EMT-getriebener metastatischer Kolonisierung (A03) (SFB/TRR 305 A03) TRR 305: Über die Analyse der metastatischen Koloniebildung zu neuen systemischen Krebstherapien Jan. 1, 2021 - Dec. 31, 2024 J097: Targeting immune-metabolic dysfunction of reconstituting NK cells upon stem cell transplantation Jan. 1, 2022 - June 30, 2024 D033: Immunometabolic interplay in pediatric chronic myeloid leukemia: from immunosuppression to synthetic lethality July 1, 2020 - June 30, 2023 P085: Generation of Duotoxins for the treatment of cancer July 1, 2021 - June 30, 2022 ZKF-J67 (M5): Metabolic Reprogramming as a Gatekeeper for Induction/Function of Myeloid Derived Suppressor Cells in AML Jan. 1, 2018 - June 30, 2021 P051: Charakterisierung Follikulärer T-Helferzellen bei Patietnen nach allogener Stammzelltransplantation Jan. 1, 2020 - Dec. 31, 2020 J059: CD22-targeting immunotoxin initiates systemic anti-lymphoma immunity in syngeneic mice July 1, 2017 - June 30, 2020